CRL Charles River Corp Expected net earnings per share growth this year

Official company branding of Charles River Laboratories (CRL)

Charles River Laboratories (CRL) attracts elite toxicologists by offering them prestigious careers and cutting-edge equipment. The company is implementing AI modeling and developing gene therapy bioprocessing to accelerate drug development. Moderate cyclicality in R&D budgets is smoothed out by long-term contracts. The YoY net income per share growth rate, as shown on this GURU.Markets chart, confirms the business's resilience, where 11.70 becomes the new value for this metric.

Charles River Laboratories International, Inc. (CRL): Earnings growth in current year from 07/04/2022 to 11/15/2026

Analytical breakdowns and data insights for company Charles River (CRL)

- share price and expert price forecast:
Price Charles River Corp|CRL - Price Target Chart
- market capitalization data:
Market Capitalization Charles River|CRL - Enterprise Value
- shareholders' equity book value data:
Accounting Value per Share Charles River|CRL - Book Capitalization|Market Value to Book Value criver.com|CRL - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Capital Charles River Laboratories|CRL - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Charles River Laboratories International, Inc.|CRL - Company Debts|Debt to Book Capitalization Ratio Charles River|CRL - Company Long-Term Debts|Short-Term Debt Charles River|Interim Coverage Ratio criver.com
- net income and valuation ratios data:
CRL - Net Income|Expected Net Income Charles River Laboratories|CRL - Price to Earnings Ratio|Future Price to Earnings Multiple Charles River Laboratories|CRL - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Charles River Laboratories International, Inc.|CRL - Operating profit before deduction of amortization|Earnings per share for the last twelve months Charles River|CRL - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months criver.com|CRL - Earnings per share growth in current year|Expected earnings per share trend next year Charles River Laboratories
- sales volume and revenue information:
CRL - Company Sales|Company Future Revenue Charles River Corp|CRL - Price-to-Revenue Ratio|Price-to-Projected Revenue Ratio Charles River
Basic company analysis:Charles River Lab, CRL
Manufactured product of criver.com

Professional managers utilize net earnings per share dynamics to assess a business's ability to generate value amid changing capital costs. This annual EPS percentage change measures the growth rate of returns, which for Charles River Laboratories (CRL) is supported by its monopoly position in preclinical research and its ability to pass costs onto customers due to inelastic demand.

Direct competitors

IQV: Net earnings per one share growth for the current year|Earnings per share growth in current year Labcorp Holdings Inc.|MEDP (medpace.com) - Net earnings per one share growth for the current year|Earnings per share growth in current year ICON Public Limited Company (ICLR)|EVO - Earnings per share growth rate in current year|Earnings growth in current year FTRE (Fortrea)|Lifecore - Earnings per share growth in current year|OABI - Earnings per share growth in current year|NOTV (inotivco.com) - Earnings per share growth this year|CDMO: Earnings growth in current year|CTLT: Net earnings per one share growth for the current year|Earnings per share growth in current year NightHawk Biosciences